Tralokinumab-Ldrm

Adbry

Interleukin-13 Antagonist

NADAC/unit N/A

No Shortage Tier 1: 7.3% PA Req: 32.5%

Covered Lives

Market Intelligence

2026-03-04 Class II Recall: LEO PHARMA INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Tralokinumab-Ldrm drfinder.aiFind doctors who prescribe Tralokinumab-Ldrm rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Tralokinumab-Ldrm

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.